Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes

Por Qin, Xiaobing, Yu, Shaorong, Xu, Xiaoyue, Shen, Bo, Feng, Jifeng
Publicado no Oncotarget (2017)

Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21

Por Jing, Changwen, Cao, Haixia, Qin, Xiaobing, Yu, Shaorong, Wu, Jianzhong, Wang, Zhuo, Ma, Rong, Feng, Jifeng
Publicado no Oncol Lett (2018)

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner

Por Qin, Xiaobing, Yu, Shaorong, Zhou, Leilei, Shi, Meiqi, Hu, Yong, Xu, Xiaoyue, Shen, Bo, Liu, Siwen, Yan, Dali, Feng, Jifeng
Publicado no Int J Nanomedicine (2017)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of...

Por Hu, Yong, Zang, Jialan, Qin, Xiaobing, Yan, Dali, Cao, Haixia, Zhou, Leilei, Ni, Jie, Yu, Shaorong, Wu, Jianzhong, Feng, Ji-Feng
Publicado no Onco Targets Ther (2017)

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro

Por Hu, Yong, Zang, Jialan, Cao, Haixia, Wu, Ying, Yan, Dali, Qin, Xiaobing, Zhou, Leilei, Fan, Fan, Ni, Jie, Xu, Xiaoyue, Sha, Huanhuan, Liu, Siwen, Yu, Shaorong, Wang, Zhuo, Ma, Rong, Wu, Jianzhong, Feng, Jifeng
Publicado no Oncotarget (2017)